Molly McKenzie
Overview
Explore the profile of Molly McKenzie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dolan R, Pennel K, Thompson J, McKenzie M, Alexander P, Richards C, et al.
BJC Rep
. 2025 Feb;
3(1):7.
PMID: 39910331
Background: In cancer cachexia the relationship between the tumour, its environment and the systemic inflammatory response is not clear. This study aims to examine this relationship in greater detail. Methods:...
2.
Shamis S, Quinn J, Al-Badran S, McKenzie M, Hatthakarnkul P, Lynch G, et al.
Cancer Med
. 2024 Dec;
13(23):e70274.
PMID: 39660488
Purpose: Carbonic anhydrase IX (CAIX) is a well-established prognostic marker in breast cancer (BC). Nevertheless, this prognostic value is yet to be confirmed in BC subtypes. This study aims to...
3.
Galbraith N, Quinn J, Al-Badran S, Pennel K, Hillson L, Hatthakarnkul P, et al.
Transl Oncol
. 2024 Jul;
48:102064.
PMID: 39068768
Background: Transforming growth factor β-activated protein kinase-1 (TAK1) plays an important role in MAPK and NFκB pathways and has been associated with colorectal cancer. The aim of this study was...
4.
McKenzie M, Lian G, Pennel K, Quinn J, Jamieson N, Edwards J
Heliyon
. 2024 Jul;
10(12):e32904.
PMID: 38975078
The NFκB pathway, known as the central regulator of inflammation, has a well-established role in colorectal cancer (CRC) initiation, progression, and therapy resistance. Due to the pathway's overarching roles in...
5.
Cong B, Stamou E, Pennel K, McKenzie M, Matly A, Gopinath S, et al.
bioRxiv
. 2024 Jan;
PMID: 38187607
Approximately 40% of colorectal cancer (CRC) cases are characterized by KRAS mutations, rendering them insensitive to most CRC therapies. While the reasons for this resistance remain incompletely understood, one key...
6.
Tan H, Yeong C, Wong Y, McKenzie M, Kasbollah A, Md Shah M, et al.
Nucl Med Biol
. 2020 Oct;
90-91:55-68.
PMID: 33039974
Theranostics in nuclear medicine refers to personalized patient management that involves targeted therapy and diagnostic imaging using a single or combination of radionuclide (s). The radionuclides emit both alpha (α)...
7.
Slewa-Younan S, McKenzie M, Thomson R, Smith M, Mohammad Y, Mond J
BMC Psychiatry
. 2020 Jun;
20(1):314.
PMID: 32552878
Background: Refugee populations have particularly high rates of mental health problems, including Posttraumatic Stress Disorder (PTSD) and depression. However, uptake of mental health care may be low even when severe...